Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6524)
All Articles published online
|
Publishing Process of This Article
|
May 18, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chok KS. Management of recurrent hepatocellular carcinoma after liver transplant. World J Hepatol 2015; 7(8): 1142-1148 [PMID: 26052403 DOI: 10.4254/wjh.v7.i8.1142] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i8/1142.htm |
| Number | Citing Articles |
| 1 |
S.S. Kim, T.W. Kang, K.D. Song, S.K. Cho, M.W. Lee, H. Rhim, D.H. Sinn, S.-H. Jung. Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers. Clinical Radiology 2017; 72(2): 141 doi: 10.1016/j.crad.2016.09.008
|
| 2 |
Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin. The management of post-transplantation recurrence of hepatocellular carcinoma. Clinical and Molecular Hepatology 2022; 28(1): 1 doi: 10.3350/cmh.2021.0217
|
| 3 |
Nicola de’Angelis, Filippo Landi, Marco Nencioni, Anais Palen, Eylon Lahat, Chady Salloum, Philippe Compagnon, Chetana Lim, Charlotte Costentin, Julien Calderaro, Alain Luciani, Cyrille Feray, Daniel Azoulay. Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation. Progress in Transplantation 2016; 26(4): 348 doi: 10.1177/1526924816664083
|
| 4 |
Brian I. Shaw, Aaron Lucander, Kadiyala V. Ravindra. Very Late Recurrence of Hepatocellular Carcinoma After Orthotopic Liver Transplantation: Presentation and Management. Transplantation Direct 2019; 5(9): e483 doi: 10.1097/TXD.0000000000000921
|
| 5 |
Kin Pan Au, Chi Leung Chiang, Albert Chi Yan Chan, Tan To Cheung, Chung Mau Lo, Kenneth Siu Ho Chok. Initial experience with stereotactic body radiotherapy for intrahepatic hepatocellular carcinoma recurrence after liver transplantation. World Journal of Clinical Cases 2020; 8(13): 2758-2768 doi: 10.12998/wjcc.v8.i13.2758
|
| 6 |
Young-Jen Lin, Cheng-Maw Ho. Is the Rationale of Anatomical Liver Resection for Hepatocellular Carcinoma Universally Adoptable? A Hypothesis-Driven Review. Medicina 2021; 57(2): 131 doi: 10.3390/medicina57020131
|
| 7 |
Wei Yang, Hao Wu, Zhong-yi Zhang, Jung-chieh Lee, Song Wang, Yan-jie Wang, Wei Wu, Min-hua Chen, Kun Yan. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation. International Journal of Hyperthermia 2018; 34(1): 68 doi: 10.1080/02656736.2017.1324179
|
| 8 |
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations. Journal of Clinical and Experimental Hepatology 2020; 10(1): 43 doi: 10.1016/j.jceh.2019.09.007
|
| 9 |
Carlo Sposito, Davide Citterio, Matteo Virdis, Carlo Battiston, Michele Droz Dit Busset, Maria Flores, Vincenzo Mazzaferro. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(34): 4929-4942 doi: 10.3748/wjg.v28.i34.4929
|
| 10 |
Bin Zhang, Zhi-yi Liu, Rui Wu, Cheng-ming Zhang, Kuan Cao, Wen-gang Shan, Zhen Liu, Ming Ji, Zi-lu Tian, Gautam Sethi, Heng-liang Shi, Ren-hao Wang. Transcriptional regulator CTR9 promotes hepatocellular carcinoma progression and metastasis via increasing PEG10 transcriptional activity. Acta Pharmacologica Sinica 2022; 43(8): 2109 doi: 10.1038/s41401-021-00812-3
|
| 11 |
Xiaoqiang Qi, Guangfu Li, Dai Liu, Anjan Motamarry, Xiangwei Huang, A. Marissa Wolfe, Kristi L. Helke, Dieter Haemmerich, Kevin F Staveley-O'Carroll, Eric T Kimchi. Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer. Cancer Biology & Therapy 2015; 16(12): 1812 doi: 10.1080/15384047.2015.1095412
|
| 12 |
Ka Wing Ma, Tan To Cheung. When to consider liver transplantation in hepatocellular carcinoma patients?. Hepatic Oncology 2017; 4(1): 15 doi: 10.2217/hep-2016-0010
|
| 13 |
Kin Pan Au, Kenneth Siu Ho Chok. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm. World Journal of Gastroenterology 2018; 24(45): 5081-5094 doi: 10.3748/wjg.v24.i45.5081
|
| 14 |
Morteza Hafezi, Anthony Tan, Antonio Bertoletti. Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent Cancer. Cells 2021; 10(8): 1861 doi: 10.3390/cells10081861
|
| 15 |
Kin-Pan Au, Wing-Chiu Dai, Albert Chi-Yan Chan, Tan-To Cheung, Chung-Mau Lo, Kenneth Siu-Ho Chok. Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence. Transplantation Direct 2021; 7(10): e769 doi: 10.1097/TXD.0000000000001213
|
| 16 |
Lee Jin Lim, Samuel Y.S. Wong, Feiyang Huang, Sheng Lim, Samuel S. Chong, London Lucien Ooi, Oi Lian Kon, Caroline G. Lee. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Research 2019; 79(20): 5131 doi: 10.1158/0008-5472.CAN-19-0255
|
| 17 |
Gian Piero Guerrini, Giuseppe Esposito, Tiziana Olivieri, Paolo Magistri, Roberto Ballarin, Stefano Di Sandro, Fabrizio Di Benedetto. Salvage versus Primary Liver Transplantation for Hepatocellular Carcinoma: A Twenty-Year Experience Meta-Analysis. Cancers 2022; 14(14): 3465 doi: 10.3390/cancers14143465
|
| 18 |
Sirina Ekpanyapong, Neil Philips, Bao-Li Loza, Peter Abt, Emma E. Furth, Rashmi Tondon, Vandana Khungar, Kim Olthoff, Abraham Shaked, Maarouf A. Hoteit, K. Rajender Reddy. Predictors, Presentation, and Treatment Outcomes of Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Large Single Center Experience. Journal of Clinical and Experimental Hepatology 2020; 10(4): 304 doi: 10.1016/j.jceh.2019.11.003
|
| 19 |
Mimi Kim, Tae Wook Kang, Woo Kyoung Jeong, Young Kon Kim, Seong Hyun Kim, Jong Man Kim, Dong Hyun Sinn, Min-Ji Kim, Sin-ho Jung. Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants. European Radiology 2017; 27(8): 3117 doi: 10.1007/s00330-016-4662-2
|
| 20 |
Wei Tan, Wenkui Sun, Xia Li, Lei Zhao, Chun Wang, Aihua Zang, Xiangchong Kong. Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation. Journal of Cancer Research and Therapeutics 2018; 14(1): 84 doi: 10.4103/jcrt.JCRT_835_17
|
| 21 |
Yongshuo Ji, Junqiu Zhu, Linglin Zhu, Yanfei Zhu, Hong Zhao. High-Intensity Focused Ultrasound Ablation for Unresectable Primary and Metastatic Liver Cancer: Real-World Research in a Chinese Tertiary Center With 275 Cases. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.519164
|
| 22 |
Ramin Raul Ossami Saidy, Maximilian Paul Postel, Michael Johannes Pflüger, Wenzel Schoening, Robert Öllinger, Safak Gül-Klein, Moritz Schmelzle, Frank Tacke, Johann Pratschke, Dennis Eurich. Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma. Cancers 2021; 13(7): 1617 doi: 10.3390/cancers13071617
|
| 23 |
Kin-Pan Au, James Yan-Yue Fung, Wing-Chiu Dai, Albert Chi-Yan Chan, Chung-Mau Lo, Kenneth Siu-Ho Chok. Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation. Journal of Clinical Medicine 2022; 11(15): 4389 doi: 10.3390/jcm11154389
|